Plasma atrial natriuretic peptide (ANP) in late pregnancy and puerperium.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 2962891)

Published in Eur J Obstet Gynecol Reprod Biol on November 01, 1987

Authors

E A Steegers1, P R Hein, A C Tan, E A Groeneveld, H W Jongsma, T J Benraad

Author Affiliations

1: Department of Obstetrics and Gynecology, St. Radboud Hospital, University of Nijmegen, The Netherlands.

Articles by these authors

Atrial natriuretic peptide after myocardial infarction. Am Heart J (1989) 2.05

Concentrations of salivary testosterone and plasma total, non-sex-hormone-binding globulin-bound, and free testosterone in normal and hirsute women during administration of dexamethasone/synthetic corticotropin. Clin Chem (1991) 1.99

Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study. Nephrol Dial Transplant (2001) 1.50

Fetal learning and memory. Lancet (2000) 1.47

Do estrogen and progesterone receptors (E2R and PR) in metastasizing endometrial cancers predict the response to gestagen therapy? Acta Obstet Gynecol Scand (1980) 1.45

Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasis. The Breast Cancer Study Group. Breast Cancer Res Treat (1991) 1.23

Umbilical cord gases in home deliveries versus hospital-based deliveries. J Reprod Med (1981) 1.22

Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer. Br J Cancer (2010) 1.21

Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia. Leukemia (2012) 1.09

Mechanisms of late decelerations in the fetal heart rate. A study with autonomic blocking agents in fetal lambs. Eur J Obstet Gynecol Reprod Biol (1979) 1.07

Human breast cancer: survival from first metastasis. Breast Cancer Study Group. Breast Cancer Res Treat (1992) 1.07

Radioenzymatic assay of plasma adrenaline and noradrenaline: evidence for a catechol-O-methyltransferase (COMT) inhibiting factor associated with essential hypertension. Clin Chim Acta (1982) 1.05

Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension. Am J Cardiol (1975) 1.03

Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancers. Cancer Res (1991) 1.03

Concordance and discordance of estrogen and progesterone receptor content in sequential biopsies of patients with advanced breast cancer: relation to survival. Eur J Cancer Clin Oncol (1984) 1.00

Abdominal pregnancy: a case report and literature review. Singapore Med J (2000) 0.99

External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extracts. Br J Cancer (1998) 0.99

Basal and human chorionic gonadotropin-stimulated 17 alpha-hydroxyprogesterone and testosterone levels in Klinefelter's syndrome. J Clin Endocrinol Metab (1978) 0.98

Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up. Breast Cancer Res Treat (1985) 0.98

Highly sensitive and specific HPLC with fluorometric detection for determination of plasma epinephrine and norepinephrine applied to kinetic studies in humans. Clin Chem (1995) 0.98

Reduced imprecision of the radioenzymatic assay of plasma catecholamines by improving the stability of the internal standards. Clin Chim Acta (1986) 0.97

Redox-dependent Brca1 transcriptional regulation by an NADH-sensor CtBP1. Oncogene (2010) 0.96

The effect of oestrogen administration on plasma testosterone, FSH and LH levels in patients with Klinefelter's syndrome and normal men. Acta Endocrinol (Copenh) (1974) 0.96

Female sex hormone replacement therapy increases serum free 1,25-dihydroxyvitamin D3: a 1-year prospective study. Clin Endocrinol (Oxf) (1999) 0.94

The reliability of the measurement of plasma renin activity by radioimmunoassay. Clin Chim Acta (1975) 0.93

The HMG-CoA reductase inhibitor simvastatin suppresses human testicular testosterone synthesis in vitro by a selective inhibitory effect on 17-ketosteroid-oxidoreductase enzyme activity. J Steroid Biochem Mol Biol (1991) 0.91

Epidermal growth factor receptor levels are lower in carcinomatous than in normal colorectal tissue. Br J Cancer (1992) 0.91

Circannual cycle in plasma testosterone levels in man. J Clin Endocrinol Metab (1976) 0.91

Determination of non-protein-bound plasma 1,25-dihydroxyvitamin D by symmetric (rate) dialysis. Anal Biochem (1998) 0.90

Plasma testosterone profiles in Cushing's syndrome. J Clin Endocrinol Metab (1977) 0.89

A comparative study of three indices of umbilical blood flow in relation to prediction of growth retardation. J Perinat Med (1987) 0.88

The effect of oral contraceptives on plasma-free and salivary cortisol and cortisone. Clin Chim Acta (1987) 0.87

Six methods for direct radioiodination of mouse epidermal growth factor compared: effect of nonequivalence in binding behavior between labeled and unlabeled ligand. Clin Chem (1991) 0.87

Direct patterning in sub-surface of stainless steel using laser pulses. Opt Express (2010) 0.87

Chronic stimulation of the pituitary-adrenal axis in rats by interleukin-1 beta infusion: in vivo and in vitro studies. Endocrinology (1992) 0.86

Haematological and biochemical profile of uncomplicated pregnancy in nulliparous women; a longitudinal study. Neth J Med (1995) 0.86

Electrical properties of tissues involved in the conduction of foetal ECG. Med Biol Eng Comput (1989) 0.86

Fetal habituation to vibroacoustic stimulation in relation to fetal states and fetal heart rate parameters. Early Hum Dev (2001) 0.86

p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer. J Clin Oncol (1998) 0.86

Growth hormone responsiveness to human pancreatic growth hormone releasing factor in acromegaly: modulatory effects of basal hormone levels and of concomitant somatostatin administration. Clin Endocrinol (Oxf) (1984) 0.86

Tumours with elevated levels of the Notch and Wnt pathways exhibit efficacy to PF-03084014, a γ-secretase inhibitor, in a preclinical colorectal explant model. Br J Cancer (2013) 0.85

Transition from pituitary-dependent to adrenal-dependent Cushing's syndrome. N Engl J Med (1988) 0.85

A sensitive radioimmunoassay of atrial natriuretic peptide in human plasma, using a tracer with an immobilized glycouril agent. Clin Chim Acta (1987) 0.85

Neonatal complications in newborns with an umbilical artery pH < 7.00. Am J Obstet Gynecol (1996) 0.85

Epidermal growth factor receptor and prognosis in human breast cancer: a prospective study. Breast Cancer Res Treat (1993) 0.85

Hypotensive effects of ovine and human corticotrophin-releasing factors in man. Eur J Clin Pharmacol (1987) 0.84

Continuous infusion of interleukin-1 beta induces a nonthyroidal illness syndrome in the rat. Endocrinology (1992) 0.83

The effect of short and long term human chorionic gonadotrophin (HCG) administration on plasma testosterone levels in Klinefelter's syndrome. Acta Endocrinol (Copenh) (1974) 0.83

Endometriosis in rhesus monkeys. Lab Anim (1982) 0.83

Prognostic significance of TP53 accumulation in human primary breast cancer: comparison between a rapid quantitative immunoassay and SSCP analysis. Int J Cancer (1996) 0.83

Prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in cytosols and pellet extracts derived from 892 breast cancer patients. Br J Cancer (1999) 0.83

Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer. Br J Cancer (1999) 0.83

Computer analysis of antepartum fetal heart rate: 1. Baseline determination. Int J Biomed Comput (1990) 0.82

Low ratio of androstenedione to testosterone in plasma and saliva of hirsute women. Clin Chem (1992) 0.82

Percentiles for gas values in human umbilical cord blood. Eur J Obstet Gynecol Reprod Biol (1983) 0.82

A direct radio-immunoassay for aldosterone: significance of endogenous cortisol. Neth J Med (1980) 0.82

3 Alpha-hydroxysteroid oxidoreductase activities in dihydrotestosterone degradation and back-formation in rat prostate and epididymis. J Steroid Biochem Mol Biol (1996) 0.82

The effect of changes in the conductive medium on the fetal ECG throughout gestation. Clin Phys Physiol Meas (1989) 0.82

Analysis of heart rate and beat-to-beat variability: Interval difference index. Am J Obstet Gynecol (1980) 0.81

Double isotope assay of aldosterone in urinary extracts with the combined use of thin-layer and paper chromatography. Clin Chim Acta (1965) 0.81

Is free thyroxine accurately measurable at room temperature? Clin Chem (1992) 0.81

Predictive value of luteinizing hormone releasing hormone (LHRH) bolus testing before and after 36-hour pulsatile LHRH administration in the differential diagnosis of constitutional delay of puberty and male hypogonadotropic hypogonadism. J Clin Endocrinol Metab (1994) 0.81

Human endothelial cell migration is stimulated by urokinase plasminogen activator:plasminogen activator inhibitor 1 complex released from endometrial stromal cells stimulated with transforming growth factor beta1; possible mechanism for paracrine stimulation of endometrial angiogenesis. Biol Reprod (1998) 0.81

The influence of glycyrrhetinic acid on plasma cortisol and cortisone in healthy young volunteers. J Clin Endocrinol Metab (1990) 0.81

Progesterone receptor activity and relapse-free survival in patients with primary breast cancer: the role of adjuvant chemotherapy. Breast Cancer Res Treat (1987) 0.81

Enhancement of the ACTH response to human CRH by pretreatment with the antiglucocorticoid RU-486. Eur J Clin Pharmacol (1987) 0.81

Chronic intraperitoneal infusion of low doses of tumor necrosis factor alpha in rats induces a reduction in plasma triglyceride levels. Cytokine (1992) 0.81

The effect of pulsating arteries on reflectance pulse oximetry: measurements in adults and neonates. J Clin Monit (1995) 0.81

The second twin. Eur J Obstet Gynecol Reprod Biol (1985) 0.80

Adjuvant chemotherapy in premenopausal patients with primary breast cancer; relation to drug-induced amenorrhoea, age and the progesterone receptor status of the tumour. Eur J Cancer Clin Oncol (1988) 0.80

Plasma adrenocorticotropin, cortisol, and aldosterone responses to corticotropin-releasing factor: modulatory effect of basal cortisol levels. J Clin Endocrinol Metab (1984) 0.80

Responsiveness of the hypophyseal-adrenocortical axis to corticotropin-releasing factor in pituitary-dependent Cushing's disease. J Clin Endocrinol Metab (1983) 0.80

Aldosterone secretion rate: radioimmunoassay versus double isotope dilution derivative assay. Clin Chim Acta (1977) 0.80

Computer analysis of antepartum fetal heart rate: 2. Detection of accelerations and decelerations. Int J Biomed Comput (1990) 0.80

Improved sensitivity to adrenocorticotrophin after purification and pre-incubation of isolated rat adrenal cells. Acta Endocrinol (Copenh) (1980) 0.80

Fetal habituation to vibroacoustic stimulation in uncomplicated postterm pregnancies. Eur J Obstet Gynecol Reprod Biol (2001) 0.80

Epidermal growth factor receptors in human breast cancer: a plea for standardisation of assay methodology. Eur J Cancer (1992) 0.80

The effect of volume expansion on atrial natriuretic peptide and cyclic guanosine monophosphate levels in young and aged subjects. J Am Geriatr Soc (1990) 0.80

The responses to repeated vibroacoustic stimulation in a fetus with trisomy 18. Eur J Obstet Gynecol Reprod Biol (2001) 0.79

Differential effect of single high dose and divided small dose administration of human chorionic gonadotropin on Leydig cell steroidogenic desensitization. J Clin Endocrinol Metab (1984) 0.79

State transitions in uncomplicated pregnancies after term. Early Hum Dev (1998) 0.79

Upper gastrointestinal endoscopy does not reassure patients with functional dyspepsia. Endoscopy (2006) 0.79

Hormone replacement therapy increases serum 1,25-dihydroxyvitamin D: A 2-year prospective study. Calcif Tissue Int (1994) 0.79

Mathematical model of the fetal cardiovascular system: the uncontrolled case. Am J Physiol (1980) 0.78

Atrial natriuretic peptide. An overview of clinical pharmacology and pharmacokinetics. Clin Pharmacokinet (1993) 0.78

Chronic hyperglycemia and insulin concentrations in fetal lambs. Am J Obstet Gynecol (1988) 0.78

Advantages of paper chromatography as a preparative step in the assay of 1,25-dihydroxyvitamin D. J Chromatogr (1993) 0.78

Early time sequence in pregnenolone metabolism to testosterone in homogenates of human and rat testis. Endocrinology (1987) 0.78

Effect of reducing uteroplacental blood flow on movements and on electrocortical activity of fetal sheep. Gynecol Obstet Invest (1987) 0.78

Atrial natriuretic peptide--the influence of various physiological and sampling conditions. Ann Clin Biochem (1987) 0.78

Mild dehydration and atrial natriuretic peptide in young and elderly subjects. Horm Metab Res (1991) 0.78

Hemodynamic effects of atrial natriuretic factor in young and elderly subjects. Clin Pharmacol Ther (1990) 0.78

The fetal ECG throughout the second half of gestation. Clin Phys Physiol Meas (1989) 0.78

Measurement of oxygen saturation by multiwavelength analyzer influenced by interspecies differences. Clin Chem (1994) 0.78

The influence of maternal exercise on the uteroplacental vascular bed resistance and the fetal heart rate during normal pregnancy. Eur J Obstet Gynecol Reprod Biol (1988) 0.77

Prognostic value of TP53 protein accumulation in human primary breast cancer: an analysis by luminometric immunoassay on 1491 tumor cytosols. Anticancer Res (1997) 0.77